יתרות מזומנים למניה YS Biopharma Co., Ltd. (LSB)

LakeShore Biopharma (LSB) strictly adheres to environmental waste disposal regulations, developing a closed-loop vaccine production ecosystem in China through government procurement. The cash per share trend from GURU.Markets shows that this metric stands at 0.00. The issuer's financial stability is moderate, as cash flows are based on government vaccination schedules and new developments.
פילוחים אנליטיים של חברת LakeShore Biopharma Co.

LakeShore Biopharma Co. minimizes operational risks through bioreactor robotization and vaccine packaging automation. By analyzing the cash per share dynamics, an investor can see the distribution of net liquidity per security. The current value of 0.00 allows for tracking the impact of cost inflation on the financial trajectory. Excess funds guarantee solvency, yet may constrain the pace of accelerated growth. This indicator serves as a key marker of the business's fundamental stability.